Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Bick

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
The Medical Clinics of North America|July 1, 1998
Antithrombin agents as anticoagulants and antithrombotics. Implications in drug developmentJ Fareed, D Callas, D A Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1983
Impact of automation on the quantitation of low molecular weight markers of hemostatic defectsJ Fareed, J M Walenga, R L Bick, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1982
Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurementsJ Fareed, H L Messmore, J M Walenga, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1984
Diagnostic efficacy of a simple radioimmunoassay test for fibrinogen/fibrin fragments containing the B beta 15-42 sequenceJ M Walenga, J Fareed, G Mariani, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Thrombogenesis in myocardial infarction and related syndromes: the role of molecular markers in diagnosis and managementJ Fareed, D A Hoppensteadt, F Leya, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Vascular damage correlates between heparin-induced thrombocytopenia and the antiphospholipid syndromeJ M Walenga, K Michal, D Hoppensteadt, et al.
Seminars in Hematology|February 4, 1999
Antithrombin agents as anticoagulants and antithrombotics: implications in drug developmentJ Fareed, D Callas, D A Hoppensteadt, et al.
Cancer Treatment Reports|March 1, 1976
Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lungW L Wilson, N C Andrews, R W Frelick, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Antithrombin agents: the new class of anticoagulant and antithrombotic drugsJ Fareed, B E Lewis, D D Callas, et al.
Clinics in Laboratory Medicine|March 1, 1995
Molecular markers of hemostatic activation. Implications in the diagnosis of thrombosis, vascular, and cardiovascular disordersJ Fareed, R L Bick, D A Hoppensteadt, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
The Medical Clinics of North America|July 1, 1998
Antithrombin agents as anticoagulants and antithrombotics. Implications in drug developmentJ Fareed, D Callas, D A Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1983
Impact of automation on the quantitation of low molecular weight markers of hemostatic defectsJ Fareed, J M Walenga, R L Bick, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1982
Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurementsJ Fareed, H L Messmore, J M Walenga, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1984
Diagnostic efficacy of a simple radioimmunoassay test for fibrinogen/fibrin fragments containing the B beta 15-42 sequenceJ M Walenga, J Fareed, G Mariani, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Thrombogenesis in myocardial infarction and related syndromes: the role of molecular markers in diagnosis and managementJ Fareed, D A Hoppensteadt, F Leya, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Vascular damage correlates between heparin-induced thrombocytopenia and the antiphospholipid syndromeJ M Walenga, K Michal, D Hoppensteadt, et al.
Seminars in Hematology|February 4, 1999
Antithrombin agents as anticoagulants and antithrombotics: implications in drug developmentJ Fareed, D Callas, D A Hoppensteadt, et al.
Cancer Treatment Reports|March 1, 1976
Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lungW L Wilson, N C Andrews, R W Frelick, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Antithrombin agents: the new class of anticoagulant and antithrombotic drugsJ Fareed, B E Lewis, D D Callas, et al.
Clinics in Laboratory Medicine|March 1, 1995
Molecular markers of hemostatic activation. Implications in the diagnosis of thrombosis, vascular, and cardiovascular disordersJ Fareed, R L Bick, D A Hoppensteadt, et al.
Pageof 12